NO330951B1 - Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse - Google Patents

Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse

Info

Publication number
NO330951B1
NO330951B1 NO20022061A NO20022061A NO330951B1 NO 330951 B1 NO330951 B1 NO 330951B1 NO 20022061 A NO20022061 A NO 20022061A NO 20022061 A NO20022061 A NO 20022061A NO 330951 B1 NO330951 B1 NO 330951B1
Authority
NO
Norway
Prior art keywords
products containing
preparing
tripeptides
product
antihypertensive tripeptides
Prior art date
Application number
NO20022061A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022061L (no
NO20022061D0 (no
Inventor
Annika Mayra-Makinen
Olli Tossavainen
Tarja Suomalainen
Janne Sahlstein
Original Assignee
Valio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Ltd filed Critical Valio Ltd
Publication of NO20022061D0 publication Critical patent/NO20022061D0/no
Publication of NO20022061L publication Critical patent/NO20022061L/no
Publication of NO330951B1 publication Critical patent/NO330951B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Water Supply & Treatment (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20022061A 1999-11-01 2002-04-30 Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse NO330951B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI992360A FI113741B (fi) 1999-11-01 1999-11-01 Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
PCT/FI2000/000942 WO2001032905A1 (en) 1999-11-01 2000-10-30 Process for producing a product containing antihypertensive tripeptides

Publications (3)

Publication Number Publication Date
NO20022061D0 NO20022061D0 (no) 2002-04-30
NO20022061L NO20022061L (no) 2002-06-28
NO330951B1 true NO330951B1 (no) 2011-08-22

Family

ID=8555541

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022061A NO330951B1 (no) 1999-11-01 2002-04-30 Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse
NO20022062A NO20022062L (no) 1999-11-01 2002-04-30 Lactobacillus helveticus som produserer antihypertensive di- og tripeptider

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20022062A NO20022062L (no) 1999-11-01 2002-04-30 Lactobacillus helveticus som produserer antihypertensive di- og tripeptider

Country Status (23)

Country Link
US (2) US6972282B1 (cs)
EP (2) EP1226267B1 (cs)
JP (2) JP3695648B2 (cs)
KR (2) KR100704441B1 (cs)
CN (2) CN1197956C (cs)
AT (2) ATE285470T1 (cs)
AU (2) AU769432B2 (cs)
CA (2) CA2388354A1 (cs)
CZ (2) CZ294146B6 (cs)
DE (2) DE60016959T2 (cs)
DK (2) DK1226230T3 (cs)
EE (2) EE200200231A (cs)
ES (2) ES2220557T3 (cs)
FI (1) FI113741B (cs)
HR (2) HRP20020378B1 (cs)
HU (2) HU226200B1 (cs)
NO (2) NO330951B1 (cs)
NZ (2) NZ518493A (cs)
PL (2) PL364790A1 (cs)
PT (2) PT1226230E (cs)
RU (2) RU2276689C2 (cs)
WO (2) WO2001032836A1 (cs)
ZA (2) ZA200203179B (cs)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
FI112031B (fi) 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
EP1509609B1 (en) 2002-06-04 2015-04-22 DSM IP Assets B.V. Protein hydrolysate rich in tripeptides
JP4499564B2 (ja) 2002-08-09 2010-07-07 セーホーエル．ハンセン アクティーゼルスカブ 抗高血圧特性を有するペプチドの製造方法
CA2509627A1 (en) * 2003-01-06 2004-07-22 Unilever Plc Fermented milk product comprising tripeptide vpp and/or ipp
TWI411441B (zh) * 2003-03-18 2013-10-11 Suntory Holdings Ltd 血管收縮素轉化酶抑制性肽類
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
WO2004098309A1 (en) * 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
JP2007529206A (ja) * 2004-03-19 2007-10-25 カンピーナ ネーダーランド ホールディング ビー．ブイ． アンジオテンシン−ｉ−変換酵素阻害特性を有する食品成分及び食品の調製方法、並びにその方法により得られる製品
US20070224285A1 (en) 2004-03-31 2007-09-27 Calpis Co., Ltd Agent for Preventing or Suppressing Hepatopathy and Functional Food for Preventing or Suppressing Hepatopathy
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006004105A1 (ja) * 2004-07-05 2006-01-12 Calpis Co., Ltd. ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法
JP2008505653A (ja) * 2004-07-12 2008-02-28 ディーエスエム アイピー アセッツ ビー．ブイ． 血圧降下タンパク質加水分解物
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
EP1796480B1 (en) 2004-09-03 2011-11-09 Chr. Hansen A/S Fermented milk proteins comprising receptor ligand and uses thereof
FR2876876B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
FR2876874B1 (fr) * 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation d'ingredients leurres
US7879804B2 (en) * 2004-12-22 2011-02-01 Dsm Ip Assets B.V. Blood pressure lowering peptides in a single enzymatic step
EP1879465A1 (en) * 2005-02-09 2008-01-23 Unilever N.V. Composition comprising peptide
ES2599859T3 (es) * 2005-02-24 2017-02-03 Dsm Ip Assets B.V. Proceso enzimático para producir I-P-P a partir de caseína kappa
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
DK1954808T3 (da) 2005-11-28 2014-04-07 Dsm Ip Assets Bv Enzympræparat, der giver en ren smag
CA2642537C (en) * 2006-02-14 2013-04-09 Calpis Co., Ltd. Vasodilator
BRPI0707837A2 (pt) * 2006-02-14 2011-05-10 Calpis Co Ltd "agente para prevenÇço de arteriosclerose, agente para supressço de espessamento vascular da Íntima e agente para melhoria da funÇço endotelial vascular"
EP1820851B9 (fr) * 2006-02-20 2012-06-27 Compagnie Gervais Danone Souches de Lactobacillus helveticus ne fermentant pas le lactose
DK1820850T3 (da) * 2006-02-20 2009-06-29 Gervais Danone Sa Nye stammer af Lactobacillus Helveticus
ES2320482T3 (es) * 2006-02-20 2009-05-22 Compagnie Gervais Danone Nuevas cepas de lactobacillus helveticus.
CN100370019C (zh) * 2006-04-21 2008-02-20 江南大学 一种具有抗高血压作用的植物乳杆菌cw006
RU2457852C2 (ru) * 2006-05-15 2012-08-10 Валио Лтд Новое применение терапевтически эффективных пептидов
CA2652388A1 (en) 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
AU2007292786B2 (en) * 2006-09-04 2013-02-14 Megmilk Snow Brand Co., Ltd. Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
EP1915913B1 (en) * 2006-10-23 2015-11-18 Nestec S.A. Taste and flavour modulation by biotransformation in milk products
DE502007004849D1 (de) * 2007-02-02 2010-10-07 May Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
WO2008123096A1 (ja) * 2007-03-27 2008-10-16 Calpis Co., Ltd. 腎不全予防剤
BRPI0915107A2 (pt) * 2008-06-12 2015-08-11 Nestec Sa Cepas de lactobacillus heveticus para produção de peptídeos hipotensivos
DE102008032828A1 (de) 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
CN102786580A (zh) * 2012-07-17 2012-11-21 上海交通大学 抗高血压活性肽ivp
CN102786579B (zh) * 2012-07-17 2014-07-09 上海交通大学 抗高血压活性肽vip
RU2580052C1 (ru) * 2014-12-24 2016-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11176, полученный на доступных питательных средах
RU2577112C1 (ru) * 2014-12-25 2016-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах
CN116762866A (zh) 2016-12-02 2023-09-19 美丽生活有限责任公司 不褐变无乳糖奶粉和制造其的方法
RU2685912C1 (ru) * 2018-03-14 2019-04-23 Федеральное государственное автономное научное учреждение "Научно-исследовательский институт хлебопекарной промышленности" Штамм бактерий lactobacillus amylolyticus, используемый для приготовления термофильной заквашенной заварки
RU2728171C2 (ru) * 2018-11-08 2020-07-28 Общество с ограниченной ответственностью "Инновационные биотехнологии" (ООО "Инбиотех") Штамм бактерий Lactobacillus helveticus T-5068, используемый в качестве закваски прямого внесения для приготовления кисломолочных продуктов
CN109517763B (zh) * 2018-12-27 2022-03-22 内蒙古农业大学 瑞士乳杆菌h11及其应用
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
WO2021195718A1 (en) * 2020-04-02 2021-10-07 Ahtesh Fatah Bashir Milk fermentation process
CN112029784A (zh) * 2020-09-16 2020-12-04 内蒙古农业大学 一个与蛋白水解能力相关的基因及基于该基因的高蛋白水解能力瑞士乳杆菌的筛选方法
KR102684805B1 (ko) 2023-12-20 2024-07-12 푸른하늘환경주식회사 우수 유출수의 정화 처리 장치
KR102687298B1 (ko) 2023-12-20 2024-07-22 푸른하늘환경주식회사 비점오염물질 저감 및 우수 정화 장치
CN117986337B (zh) * 2024-02-02 2024-08-16 杭州御寿生物科技有限公司 一种提高免疫力的益生菌组合物以及在治疗疾病中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483748A1 (fr) * 1980-06-06 1981-12-11 Corning Glass Works Procede d'hydrolyse du lactose contenu dans les lactoserums a l'aide de lactase immobilisee
SU1264889A1 (ru) * 1984-07-25 1986-10-23 Киевский Ордена Трудового Красного Знамени Технологический Институт Пищевой Промышленности Способ производства молочно-белкового продукта дл плавлени
JPS6153216A (ja) * 1984-08-23 1986-03-17 Rikagaku Kenkyusho 高血圧症予防治療剤
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP2782153B2 (ja) 1992-11-09 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害ペプチドの製造法
JP2824821B2 (ja) 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
GB2294191B (en) * 1994-10-06 1997-10-01 Waterford Creamery Ltd Cheese manufacture
JP3782837B2 (ja) 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法
JPH09188694A (ja) 1996-01-10 1997-07-22 Otsuka Shokuhin Kk ペプチド、アンジオテンシン変換酵素阻害組成物及びその製法
JP3746556B2 (ja) 1996-02-09 2006-02-15 カルピス株式会社 プラスミド及びプラスミドベクター
US5854029A (en) 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
GB9720633D0 (en) * 1997-09-29 1997-11-26 Univ Bristol BHV-2 vector
FI104783B (fi) * 1998-02-12 2000-04-14 Valio Oy Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
US6514941B1 (en) * 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides

Also Published As

Publication number Publication date
PT1226267E (pt) 2004-08-31
FI19992360L (fi) 2001-05-02
NO20022061L (no) 2002-06-28
US6890529B1 (en) 2005-05-10
HRP20020378B1 (en) 2005-06-30
DK1226230T3 (da) 2005-04-04
NO20022061D0 (no) 2002-04-30
US6972282B1 (en) 2005-12-06
AU1149901A (en) 2001-05-14
RU2276689C2 (ru) 2006-05-20
HRP20020378A2 (en) 2003-08-31
EP1226267B1 (en) 2004-05-12
CZ302271B6 (cs) 2011-01-19
DE60016959D1 (de) 2005-01-27
ATE266735T1 (de) 2004-05-15
CA2387738C (en) 2008-09-16
HUP0203256A2 (hu) 2003-01-28
CN1164761C (zh) 2004-09-01
ZA200203179B (en) 2003-07-22
EE05461B1 (et) 2011-08-15
DE60010742D1 (de) 2004-06-17
DE60016959T2 (de) 2005-12-22
CA2388354A1 (en) 2001-05-10
CN1387577A (zh) 2002-12-25
KR20020064895A (ko) 2002-08-10
HUP0203256A3 (en) 2005-11-28
ES2234686T3 (es) 2005-07-01
PL204119B1 (pl) 2009-12-31
NZ518470A (en) 2003-03-28
HU226200B1 (en) 2008-06-30
NO20022062L (no) 2002-06-28
EP1226230B1 (en) 2004-12-22
WO2001032836A1 (en) 2001-05-10
CN1197956C (zh) 2005-04-20
CZ294146B6 (cs) 2004-10-13
JP2003513621A (ja) 2003-04-15
JP3695648B2 (ja) 2005-09-14
HRP20020377A2 (en) 2003-08-31
NO20022062D0 (no) 2002-04-30
CA2387738A1 (en) 2001-05-10
HUP0203185A2 (hu) 2003-01-28
HUP0203185A3 (en) 2005-07-28
RU2270855C2 (ru) 2006-02-27
KR100718709B1 (ko) 2007-05-16
CN1387564A (zh) 2002-12-25
FI113741B (fi) 2004-06-15
ATE285470T1 (de) 2005-01-15
KR20020060220A (ko) 2002-07-16
PT1226230E (pt) 2005-04-29
CZ20021431A3 (cs) 2002-08-14
AU777795B2 (en) 2004-10-28
JP4172681B2 (ja) 2008-10-29
DE60010742T2 (de) 2005-05-12
WO2001032905A1 (en) 2001-05-10
CZ20021369A3 (cs) 2002-07-17
PL355670A1 (pl) 2004-05-04
HRP20020377B1 (en) 2005-06-30
EE200200230A (et) 2003-06-16
AU769432B2 (en) 2004-01-29
PL364790A1 (pl) 2004-12-13
EE200200231A (xx) 2003-06-16
EP1226230A1 (en) 2002-07-31
ES2220557T3 (es) 2004-12-16
JP2003513636A (ja) 2003-04-15
DK1226267T3 (da) 2004-09-20
AU1149801A (en) 2001-05-14
KR100704441B1 (ko) 2007-04-24
NZ518493A (en) 2003-03-28
ZA200203172B (en) 2003-09-23
EP1226267A1 (en) 2002-07-31

Similar Documents

Publication Publication Date Title
NO330951B1 (no) Fremgangsmate for a fremstille produkter inneholdende antihypertensive tripeptider og produkter inneholdende disse
DE60327422D1 (de) Verfahren zur stabilisierung von ubichinol in lebensmitteln
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
IL151338A0 (en) Cultured protein hydrolysate
DK0973408T3 (da) Spiseis med bløde tilsætninger
FI970518A0 (fi) Majoneesin tapainen tuote ja menetelmä sen valmistamiseksi
DE69105654D1 (de) Protein-Dispersionen in Nahrungsmitteln.
DE69831420D1 (de) Herstellung von nahrungsmitteln durch fermentierung von sojamilch mit streptococcus thermophilus
ATE370664T1 (de) Nahrungsmittelzusatz
DK1562442T3 (da) Fremgangsmåde til fremstilling af mikrobiologiske stabile proteinsuspensioner
TW200511935A (en) Composition with heart rate reducing properties
ATE376361T1 (de) Fermentiertes, sojaproteine enthaltendes lebensmittel
BG108541A (en) Bread products of higher biological values

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees